.0001 to .0009 PICKS ONLY

[I Like Bottom Fishing]

News for 'PDMI' - (ARVO Meeting Yields Positive Results for Paradigm)

PDMI News -- ARVO Meeting Yields Positive Results for Paradigm

Thursday, May 20, 2010 6:40 AM

Scottrade.com
This email is compliments of Scottrade.com

News for 'PDMI' - (ARVO Meeting Yields Positive Results for Paradigm)

SALT LAKE CITY, UT, May 20, 2010 (MARKETWIRE via COMTEX) -- Paradigm Medical
Industries, Inc. (PINKSHEETS: PDMI) announced today that attendance at the
recent Association for Research in Vision and Ophthalmology (ARVO) meeting, held
in Ft. Lauderdale, Florida from May 2-5, 2010 exceeded expectations. "The ARVO
meeting was an excellent opportunity for Paradigm to continue to develop
cooperative professional relationships and introduce the Paramax, a new device
currently under FDA review pursuant to a 510(k) application. The meeting also
resulted in several new product development opportunities," said Stephen Davis,
the Company's President and CEO.

The ARVO Meeting was attended by Mr. Davis and Julio Maximo, the Company's Vice
President of Operations. Although the meeting format is not generally considered
a "selling" meeting, Paradigm actually sold over $125,000 of its equipment. The
Company also received many leads that might result in future sales of its
equipment.

During the time spent in Ft. Lauderdale, Mr. Davis met with new product
developers, development engineers, financial partners and many physicians who
represent leadership roles in the ophthalmic industry. "I am pleased with the
results of the time spent with companies and individuals at the meeting, but I
am more pleased with the renewed interest in our current and new products. This
meeting will definitely help put Paradigm Medical back on the map," added Mr.
Davis.

About Paradigm Medical Industries, Inc.

Paradigm Medical Industries, Inc. is a medical device company that develops,
manufactures and distributes ophthalmic diagnostic instruments and related
products for early detection of glaucoma and other eye disorders. The Company's
primary objective is to capture a niche market within the glaucoma and
ultrasound microscopy fields. The Company markets its products to
ophthalmologists, optometrists, universities, and clinics throughout the United
States and internationally.

This press release contains statements that, if not verifiable historic fact,
may be viewed as forward-looking statements that could predict future events and
outcomes with respect to Paradigm and its business. The predictions embodied in
these statements will involve risk and uncertainties and, accordingly, actual
results may differ significantly from the results discussed or implied in such
forward-looking statements.





Contact:

Stephen L. Davis

President and Chief Executive Officer

801-977-8970

www.paradigm-medical.com





SOURCE: Paradigm Medical Industries, Inc.




CONTACT: http://www.paradigm-medical.com




Copyright 2010 Marketwire, Inc., All rights reserved.

-0-




SUBJECT CODE: Medical and Healthcare:Dentistry

Medical and Healthcare:Facilities and Providers

Medical and Healthcare:Health and Nutrition

Medical and Healthcare:Healthcare

Pharmaceuticals and Biotech:Equipment and Supplies

Medical and Healthcare:Mental Health

Medical and Healthcare:Nursing

Medical and Healthcare:Surgery and Treatments

Medical and Healthcare:Medical Devices

Medical and Healthcare:Alternative

Source: Comtex Wall Street News